Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia
Clinical trial NCT02458287 · COMPLETED
Trial details
- NCT number
- NCT02458287
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-02-01
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.